Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Rivera

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
BMC Medicine|December 15, 2025
A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunityConstanza Méndez, Linmar Rodríguez-Guilarte, Pablo A Palacios, et al.
Mbio|August 10, 2022
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of ConcernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2021
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in ChileSusan M Bueno, Katia Abarca, Pablo A González, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trialSusan M Bueno, Katia Abarca, Pablo A González, et al.
Mbio|November 16, 2022
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in ChildrenJorge A Soto, Felipe Melo-González, Cristián Gutierrez-Vera, et al.
Human Mutation|May 28, 2019
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classificationMichael T Parsons, Emma Tudini, Hongyan Li, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
BMC Medicine|December 15, 2025
A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunityConstanza Méndez, Linmar Rodríguez-Guilarte, Pablo A Palacios, et al.
Mbio|August 10, 2022
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of ConcernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2021
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in ChileSusan M Bueno, Katia Abarca, Pablo A González, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trialSusan M Bueno, Katia Abarca, Pablo A González, et al.
Mbio|November 16, 2022
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in ChildrenJorge A Soto, Felipe Melo-González, Cristián Gutierrez-Vera, et al.
Human Mutation|May 28, 2019
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classificationMichael T Parsons, Emma Tudini, Hongyan Li, et al.
Pageof 4